Quantitative Susceptibility Mapping of a Human Brain Using Ex-Vivo Magnetic Resonance Imaging
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:09 min • May 30th, 2025
Loading...
Overview
This article outlines the process of quantitative susceptibility mapping (QSM) using ex-vivo MRI data from a fixed human brain hemisphere. QSM enables quantification of magnetic susceptibility in brain tissue, providing insights into its cellular composition, such as myelin content.
Key Study Components
Area of Science
- Neuroimaging
- Magnetic Resonance Imaging (MRI)
- Brain tissue analysis
Background
- Magnetic susceptibility reflects the cellular makeup of brain tissue.
- QSM is a technique that quantifies these susceptibility differences.
- Ex-vivo MRI allows for detailed imaging of fixed brain tissue.
- Artifact removal is crucial for accurate susceptibility mapping.
Purpose of Study
- To demonstrate the workflow for generating quantitative susceptibility maps from ex-vivo human brain MRI data.
- To highlight methods for artifact reduction and signal enhancement.
- To provide a reproducible approach for quantifying brain tissue susceptibility.
Methods Used
- Acquisition of ex-vivo MRI data from a fixed human brain hemisphere.
- Application of 3D gradient magnetic fields to magnetize tissue.
- Collection of MRI signals at multiple echo times to reduce noise and artifacts.
- Generation of phase maps for all echoes and removal of air-related artifacts.
- Creation of a total field map using MRI data processing tools.
- Background magnetic field removal while preserving tissue-specific variations.
- Generation of susceptibility maps using specialized algorithms and suppression of streaking artifacts.
Main Results
- Successful acquisition of high-quality ex-vivo MRI data.
- Effective reduction of background noise and imaging artifacts.
- Generation of accurate phase and total field maps.
- Production of quantitative susceptibility maps reflecting brain tissue properties.
Conclusions
- QSM provides a robust method for quantifying magnetic susceptibility in brain tissue.
- Careful artifact removal and signal processing are essential for accurate mapping.
- This workflow enables detailed analysis of brain tissue composition ex-vivo.
Frequently Asked Questions
What is quantitative susceptibility mapping (QSM)?
QSM is an MRI-based technique that quantifies the magnetic susceptibility of tissues, providing information about their cellular composition, such as myelin content.
Why use ex-vivo MRI for QSM?
Ex-vivo MRI allows for high-resolution imaging of fixed brain tissue, enabling detailed analysis without motion artifacts present in in-vivo studies.
How are artifacts minimized during QSM?
Artifacts are reduced by collecting signals at multiple echo times, removing air-related artifacts, and using specialized algorithms to suppress streaking artifacts in the susceptibility maps.
What is the significance of phase maps in this workflow?
Phase maps are generated for all echoes to capture magnetic field variations, which are essential for creating accurate susceptibility maps.
What does the susceptibility map reveal about brain tissue?
The susceptibility map quantifies variations in magnetic susceptibility, reflecting differences in tissue composition such as myelin and iron content.
What tools are used for MRI data processing in QSM?
Specialized MRI data processing tools and algorithms are used to generate total field maps, remove background fields, and create susceptibility maps.
Executive Industry Relevance
Quantitative susceptibility mapping (QSM) using ex-vivo MRI enables precise quantification of brain tissue magnetic properties, directly informing cellular composition such as myelin content. This capability supports mechanistic de-risking and target validation in neurodegeneration and demyelination research. Integrating artifact-suppressed QSM data enhances predictive confidence at key discovery and preclinical inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of tissue composition relevant to neurological targets.
- Supports biological de-risking by distinguishing myelin and iron content in brain regions.
- Facilitates predictive confidence in target engagement and mechanism-of-action studies.
Screening & Assay Development
- Provides validated imaging readouts for downstream assay development.
- Standardizes artifact removal and signal enhancement for reproducible outputs.
- Enables robust comparison of compound effects on tissue susceptibility in screening workflows.
Translational & Preclinical Research
- Aligns imaging biomarkers with disease-relevant tissue changes in preclinical models.
- Supports continuity from discovery through preclinical validation by quantifying tissue alterations.
- Improves risk-adjusted advancement decisions based on quantitative imaging endpoints.
Pipeline & Workflow Integration
QSM integrates into the neuroimaging discovery continuum, bridging early discovery, lead identification, and preclinical research with quantitative, reproducible tissue characterization.
- Discovery Biology: Quantifies tissue susceptibility to clarify mechanistic hypotheses and validate targets.
- Screening: Delivers standardized, artifact-suppressed imaging outputs for assay readiness.
- Analytics: Provides quantitative phase and susceptibility maps for cross-condition comparison.
- Translational Research: Links imaging findings to disease-relevant tissue changes in preclinical models.
- Enterprise Reuse: Establishes a reproducible imaging workflow adaptable across neurodegenerative research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neuroimaging studies.
- Operational Value: Standardizes artifact removal and data processing for reproducibility and scalability.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization of neurological targets and programs.
Implementation Considerations
- Requires expertise in MRI acquisition and advanced data processing algorithms.
- Demands access to high-field MRI instrumentation and specialized software tools.
- Necessitates cross-team standardization of artifact removal and phase mapping protocols.
- Adaptation may be needed for different tissue types or disease models.
- Artifact suppression and signal enhancement are critical for reliable quantitative outputs.
Biopharma FAQs
Why does null hypothesis testing matter for QSM-based target validation?
Null hypothesis testing in QSM studies ensures that observed differences in tissue susceptibility are statistically significant, supporting robust target validation and reducing false positives in neuroimaging research.
How does independent variable isolation fit in ex-vivo MRI workflows?
Isolating variables such as tissue type or fixation state during ex-vivo MRI acquisition allows for precise attribution of susceptibility changes, strengthening mechanistic insights and discovery-stage decision making.
What do quantitative susceptibility maps enable in neuroimaging pipelines?
Quantitative susceptibility maps provide reproducible, artifact-suppressed measurements of tissue composition, enabling direct comparison across conditions and supporting translational biomarker development.
Why are replication requirements critical for artifact-suppressed QSM outputs?
Replication ensures that artifact-suppressed QSM outputs are reliable and reproducible across samples and teams, facilitating cross-functional collaboration and enterprise-wide data confidence.
What statistical analysis capabilities are needed before QSM implementation?
Robust statistical analysis tools are required to assess significance, control for artifacts, and validate quantitative outputs, ensuring that QSM data can inform portfolio-level R&D decisions.
09:30
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
Related Videos
0 Views
08:16
High-resolution Structural Magnetic Resonance Imaging of the Human Subcortex In Vivo and Postmortem
Related Videos
0 Views
08:26
Quantitative Mapping of Specific Ventilation in the Human Lung using Proton Magnetic Resonance Imaging and Oxygen as a Contrast Agent
Related Videos
0 Views
06:04
Functional Mapping with Simultaneous MEG and EEG
Related Videos
0 Views
09:08
Multiple-mouse Neuroanatomical Magnetic Resonance Imaging
Related Videos
0 Views
10:06
High-resolution Functional Magnetic Resonance Imaging Methods for Human Midbrain
Related Videos
0 Views
08:36
Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Related Videos
0 Views
04:45
Assessing Brain Hyperexcitability with Transcranial Magnetic Stimulation and Electroencephalography
Related Videos
0 Views
09:06
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Related Videos
0 Views
06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Related Videos
0 Views
Last updated: 18 July 2026